Dr. Sue Rosenberg joins BriaCell Scientific Advisory Board

Suzanne Ostrand-Rosenberg, Professor Emerita,  has joined the BriaCell Scientific Advisor Board. BriaCell is a a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers. 

Read more: https://www.globenewswire.com/news-release/2021/11/05/2328584/0/en/BriaCell-Adds-Pioneering-Immunologist-and-Cancer-Immunotherapy-Expert-Suzanne-Ostrand-Rosenberg-Ph-D-to-its-Scientific-Advisory-Board.html.